The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTILS.L Share News (TILS)

  • There is currently no data for TILS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Airtel And Telkom Abort Kenya Combination

Wed, 05th Aug 2020 22:03

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Airtel Africa PLC - Africa-focused mobile operator - Subsidiary Airtel Networks Kenya Ltd and Telkom Kenya Ltd business combination in Kenya falls through after "a very lengthy process which has led the parties to reconsider their stance". The two businesses are no longer pursuing completion of the combination.

----------

Adamas Finance Asia Ltd - pan-Asian diversified investment vehicle - Says Future Metal Holdings Ltd asset quarry set to operate at full production for the rest of 2020 after a temporary pause in early 2020 amid the Covid-19 pandemic. Quarry operations in Future Metal's open-pit dolomite quarry in Shanxi Province, China resumed in mid-March. Adamas says that, given the "continuing rapid urbanisation" in China, demand for Future Metal's product is likely to say "robust".

----------

Regency Mines PLC - battery metals company - Proposes name change to Corcel PLC with the aim of more closely reflecting its "strategy to develop its businesses across the battery metals exploration and flexible grid solutions space." Application for name change being made to Companies House and a new website it to be launched.

----------

TP Group PLC - Reading-based software solutions provider - Subsidiary Sapienza Consulting chosen to participate in framework contract providing consulting and technical services for Eurocontrol. Framework to last up to five years and relates to "Common IT Contractor Profiles at the Maastricht Upper Area Control Centre (MUAC) in the Netherlands." Eurocontrol to release restricted tenders to pre-qualified participants for "a range of specialist capabilities" under this framework. Eurocontrol described by TP as "a pan-European civil-military organisation dedicated to supporting European aviation".

----------

MediaZest PLC - London-based audio visual services provider - Raises GBP150,000 through issue of unsecured convertible loan notes with maturity date August 2023. Proceeds will provide more working capital for MediaZest and have interest of 7% per annum. Chief Executive Geoff Robertson: "We are delighted to announce the fundraise at a difficult time for all businesses and we're grateful for the continuing support of shareholders as we move out of the UK lockdown period and seek to build on the group's encouraging performance in the run up to the Covid-19 outbreak."

----------

Hummingbird Resources PLC - African gold producer - Provides second quarter operational and trading update on Yanfolila showing 24,054 ounces gold poured in period, down from 27,466 ounces in the same quarter of 2019. Sells 31,520 ounces of gold at USD1,663 average price per ounce. All in sustaining cost for Yanfolila USD963 per ounce versus USD998 year-on-year. Recordable injury frequency rate 2.3, under 2.5 target. June 30 cash USD6 million versus USD9 million December 31 and 4,000 ounces gold inventory on hand compared to 2.900 ounced 2019 end worth around USD8 million. Reduces bank debt by USD14 million from December to USD26 million. Maintains 2020 guidance for 11,000 to 125,000 ounces and ASIC USD995 per ounce. On track for net cash position target in second half with bank loans repaid by end of 2021 first half. Q2 Yanfolila mine drill intersections received includes 5.7 metres at 16.42 grams per tonne of ore from 263 metres depth.

----------

IQ-AI Ltd - medical software company with headquarters in Jersey - Signs letter of intent with undisclosed "major international medical group" that wishes to buy StoneChecker Software Ltd. The sale is part of IQ-AI's decision to focus on neuro imaging. StoneChecker analyses CT assets the evaluate the likelihood of a kidney stone breaking up when a patient undergoes lithotripsy, where shock waves are used to break up kidney stones. This procedure fails 29% of the time and StoneChecker would therefore reduce the the number of these failed procedures. If completed, the sales will involve a cash consideration as well as ongoing royalty on sales.

----------

Cora Gold Ltd - West African focused gold company - Says warrant holders have exercised their right to subscribe for 55,564 depositary interests at 10 pence each, raising GBP55,556 in total.

----------

NB Global Floating Rate Income Fund Ltd - closed-ended investment company incorporated in Guernsey - Intends to propose investment policy amendment and institure new discount control mechanism. This includes a revised investment objective letting it invest in a broader range of assets such as alternative credit. It will also pay income on a monthly basis starting from the declaration of its third quarter dividend. It explains: "The new investment objective will mean the trust can still invest in 'senior secured, floating rate' loans where the majority of its portfolio is currently held, but will also be able to invest in a broad range of other debt types." New proposals will involve a tender offer to let shareholder exist the trust, which is trading on an 8% discount, at a 2% discount. The discount control policy will let investors tender shares at a 3% discount every six months.

----------

Tiziana Life Sciences PLC - London-headquartered biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases - Closes American Depositary Shares registered direct offering. Issues 11.0 million ADSs as USD5.20 each raising USD57.25 million gross. ThinkEquity, division of Fordham Financial Management Inc, is sole placement agenct. Proceeds will help advance clinical development of Foralumab and allow it to start a trial in HCC patients with Milciclib. Funds also assist in expediating clinical development of TZLS-501 for Covid-19.

----------

Columbus Energy Resources PLC - oil and gas producer and explorer focused on onshore Trinidad and Suriname - Gets court sanction for scheme to effect merger with Bahamas Petroleum Co PLC, expected to be effective August 7. August 6 to be last day of dealings in Columbus shares.

----------

By Anna Farley; annafarley@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
4 Dec 2019 15:38

Tiziana initiates study of 'Foralumab' in coated capsule form

(Sharecast News) - Clinical-stage biotechnology company Tiziana Life Sciences announced the initiation of a phase 1 clinical trial in healthy volunteers on Wednesday, with a proprietary oral formulation of 'Foralumab' encapsulated in enteric-coated capsules.

Read more
4 Dec 2019 11:52

Tiziana Life Sciences Kicks Off Oral Trials Of Antibody Foralumab

Tiziana Life Sciences Kicks Off Oral Trials Of Antibody Foralumab

Read more
20 Nov 2019 13:02

Tiziana Life Sciences Settles Fee; Director Zambeletti Departs

Tiziana Life Sciences Settles Fee; Director Zambeletti Departs

Read more
1 Nov 2019 17:31

Tiziana Life Sciences Issues GBP1.4 Million Convertible Loan Notes

Tiziana Life Sciences Issues GBP1.4 Million Convertible Loan Notes

Read more
30 Sep 2019 10:27

Tiziana Loss Narrows In "Busy" First Half, Looks To Advance Drug Tests

Tiziana Loss Narrows In "Busy" First Half, Looks To Advance Drug Tests

Read more
16 Sep 2019 13:03

Tiziana Life Sciences Gets New Foralumab Formulation US Trial Approval

(Alliance News) - Tiziana Life Sciences PLC on Monday said the US Food & Drug Adminsitration has allowed the company to begin a phase 1 clinical trial of its novel Foralumab formulation in in

Read more
10 Sep 2019 14:34

Tiziana Life Sciences Announces Positive Data From Foralumab Trial

(Alliance News) - Tiziana Life Sciences PLC on Tuesday said data from its phase 1 trial of Foralumab showed the drug "was well-tolerated at all doses" and produced a positive biomarker a

Read more
4 Sep 2019 11:04

Encouraging Data From Tiziana Life Sciences Milciclib Cancer Study

(Alliance News) - Tiziana Life Sciences PLC on Wednesday announced positive data from its study of Milciclib in patients with advanced liver cancer.Shares in Tiziana were up 19% at 57.00 in

Read more
22 Jul 2019 09:54

Tiziana Reports No Drug-Related Deaths In Milciclib Liver Cancer trial

(Alliance News) - Tiziana Life Sciences PLC on Monday said there were no drug related deaths in its phase 2a trial of Milciclib in advanced liver cancer and the drug was well tolerated with some 6

Read more
1 Jul 2019 10:49

WINNERS & LOSERS SUMMARY: Future Rises After Positive Annual Outlook

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------DS Smith,

Read more
1 Jul 2019 10:20

Tiziana Notes Positive Study Of Drug Similar To Foralumab In Diabetes

(Alliance News) - Tiziana Life Sciences PLC on Monday noted a study in which a drug similar to Foralumab was shown to delay the onset of type-1 diabetes.Shares in the biotechnology company

Read more
1 May 2019 10:08

FDA asks Tiziana for more information on next 'foralumab' trial

(Sharecast News) - Biotechnology company Tiziana Life Sciences updated the market in its 'Investigational New Drug' (IND) application to the US Food and Drug Administration (FDA) on Wednesday, to initiate a phase 1 clinical trial of enteric-coated capsules of its 'foralumab' product in healthy volunteers.

Read more
24 Apr 2019 12:20

Most Patients Stick With Milciclib In Tiziana Life Sciences Study

LONDON (Alliance News) - Tiziana Life Sciences PLC on Wednesday reported encouraging interim data from its trial of milciclib in patients with advanced liver cancer.Shares in Tiziana were -

Read more
4 Apr 2019 10:58

Tiziana Life Sciences Annual Loss Narrows On Marginally Reduced Costs

LONDON (Alliance News) - Tiziana Life Sciences PLC on Thursday reported a slight reduction in its annual loss as costs were reduced.For 2018, the clinical stage biotechnology company posted

Read more
20 Mar 2019 13:01

Tiziana Life Sciences Submits Application For Foralumab Trial In US

LONDON (Alliance News) - Tiziana Life Sciences PLC on Wednesday said it has submitted an application in the US to begin a phase one trial of its autoimmune and inflammatory disease drug new drug a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.